Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aytu Biopharma Inc
(NQ:
AYTU
)
1.508
UNCHANGED
Streaming Delayed Price
Updated: 3:58 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.508
Bid (Size)
0.5960 (2)
Ask (Size)
1.990 (1)
Prev. Close
1.508
Today's Range
1.508 - 1.508
52wk Range
1.410 - 3.450
Shares Outstanding
5,567,490
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
November 13, 2024
Via
ACCESSWIRE
Earnings Scheduled For November 13, 2024
November 13, 2024
Via
Benzinga
Performance
YTD
-47.81%
-47.81%
1 Month
-31.76%
-31.76%
3 Month
-38.94%
-38.94%
6 Month
-52.57%
-52.57%
1 Year
-39.91%
-39.91%
More News
Read More
Aytu BioPharma's Earnings: A Preview
November 12, 2024
Via
Benzinga
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
November 06, 2024
Via
ACCESSWIRE
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
October 14, 2024
Via
ACCESSWIRE
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
October 01, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 27, 2024
Via
Benzinga
Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results
September 26, 2024
Via
ACCESSWIRE
Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations
August 06, 2024
Via
ACCESSWIRE
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
June 18, 2024
Via
ACCESSWIRE
Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024
September 16, 2024
Via
ACCESSWIRE
Sidoti Events, LLC's Virtual August Micro-Cap Conference
August 13, 2024
Via
ACCESSWIRE
Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024
August 08, 2024
Via
ACCESSWIRE
Lytham Partners Spring 2024 Investor Conference Starts Tomorrow, May 30, 2024
May 29, 2024
Via
Newsfile
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
April 03, 2024
Via
ACCESSWIRE
Earnings Scheduled For February 14, 2024
February 14, 2024
Via
Benzinga
Earnings Preview: Aytu BioPharma
February 13, 2024
Via
Benzinga
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
November 30, 2023
Via
ACCESSWIRE
Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
May 23, 2024
Via
ACCESSWIRE
AYTU Stock Earnings: Aytu BioPharma Beats EPS, Beats Revenue for Q3 2024
May 15, 2024
Via
InvestorPlace
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
May 08, 2024
Via
ACCESSWIRE
Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter
February 14, 2024
Via
ACCESSWIRE
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
February 07, 2024
Via
ACCESSWIRE
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
January 23, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 22, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.